Circulating Cathodic Antigen Test Compared to Microscopy for Diagnosis of Urinary Schistosomiasis in Sohag
NCT05276414 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-04-08
Summary
Schistosomiasis is a chronic infection endemic in 74 tropical and sub-tropical countries. Sub-Saharan Africa carries the highest burden (90%) of schistosomiasis which caused by both Schistosoma mansoni and Schistosoma haematobium. The prevalence of Schistosomiasis should be assessed to control of the infection. This is usually achieved through surveys based on the use of traditional parasitological methods as urine filtration for S. haematobium. However, these traditional methods are time consuming, require an experienced technician and multiple samples due to light-infection and irregular shedding. Therefore, the point-of-care Circulating Cathodic Antigen (POC-CCA) urine test has been developed for the diagnosis of S. haematobium infection which is simple, rapid, sensitive and specific assay.
Conditions
- Urinary Schistosomiases
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Asmaa K Abd Ellah, lecturer · Medical Parasitology, Faculty of Medicine, Sohag University
Eligibility
- Min Age
- 5 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-15
- Primary Completion
- 2022-09-30
- Completion
- 2022-10-30
Countries
- Egypt
Study Locations
More Related Trials
-
Performance of Tests for Schistosoma Haematobium Diagnosis
NCT06808750 ·Status: COMPLETED
-
Urinary Schistosomiasis Infection
NCT00138450 ·Status: COMPLETED
-
Detection of Schistosomiasis CAA in Travellers After High-risk Water Contact
NCT02194712 ·Status: COMPLETED
-
Schistosomiasis Diagnosis Using a CAA Antigen Test
NCT03779347 ·Status: UNKNOWN ·Phase: PHASE3
-
Repeated Controlled Human Schistosoma Mansoni Infection
NCT05085470 ·Status: COMPLETED ·Phase: NA
-
Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach
NCT06311344 ·Status: RECRUITING ·Phase: NA
-
Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding
NCT02755324 ·Status: COMPLETED ·Phase: NA
-
Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control
NCT00463632 ·Status: COMPLETED
-
Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes
NCT00463593 ·Status: COMPLETED
-
Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology
NCT02878564 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
NCT01541631 ·Status: UNKNOWN ·Phase: NA
-
Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso
NCT00463528 ·Status: COMPLETED
-
Parasitological Evaluation of Fascioliasis in Clinically Suspected Patients .
NCT03869788 ·Status: UNKNOWN
-
Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery
NCT01931826 ·Status: COMPLETED ·Phase: NA
-
Schistosoma Mansoni Morbidity in Children Aged 1-5 Years
NCT01901484 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
NCT02734186 ·Status: WITHDRAWN ·Phase: PHASE4
-
Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment
NCT02495909 ·Status: COMPLETED
-
Female Genital Schistosomiasis in Tanzania
NCT05788003 ·Status: UNKNOWN ·Phase: NA
-
Single-sex Female Controlled Human Schistosomiasis Mansoni Infection
NCT04269915 ·Status: COMPLETED ·Phase: NA
-
Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana
NCT00463931 ·Status: COMPLETED
-
Health Benefits of Repeated Treatment in Pediatric Schistosomiasis
NCT01424410 ·Status: COMPLETED
-
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
NCT00215267 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Drug Combinations Against Schistosomiasis
NCT01050374 ·Status: COMPLETED ·Phase: NA
-
Strongyloidiasis at CHRU Nancy: Evaluation of the Performance of Serological Tests and Disease-associated Characteristics
NCT07296198 ·Status: COMPLETED
-
Evaluation of an AI-DP for STH Deworming Programs: a Study Protocol
NCT06055530 ·Status: UNKNOWN